Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
about
Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical developmentInhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia.Targeting the mTOR pathway in breast cancer.Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment.
P2860
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Integrated molecular pathway a ...... s for basal-like breast cancer
@ast
Integrated molecular pathway a ...... s for basal-like breast cancer
@en
type
label
Integrated molecular pathway a ...... s for basal-like breast cancer
@ast
Integrated molecular pathway a ...... s for basal-like breast cancer
@en
prefLabel
Integrated molecular pathway a ...... s for basal-like breast cancer
@ast
Integrated molecular pathway a ...... s for basal-like breast cancer
@en
P2093
P2860
P1433
P1476
Integrated molecular pathway a ...... s for basal-like breast cancer
@en
P2093
Hanina Hibshoosh
Hugo M Horlings
Jorma Isola
Lao H Saal
Lorenzo Memeo
Matthew Maurer
Meaghan Dendy
Mervi Jumppanen
Neal Rosen
Qing-Bai She
P2860
P2888
P356
10.1186/S12885-016-2609-2
P407
P577
2016-08-02T00:00:00Z
P6179
1049913035